Long-term ganciclovir therapy for hepatitis B virus infection after liver transplantation
- 1 October 1999
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 31 (4) , 584-592
- https://doi.org/10.1016/s0168-8278(99)80335-3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- De novo and apparent de novo hepatitis B virus infection after liver transplantationJournal of Hepatology, 1997
- Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosisThe Lancet, 1996
- EFFICACY OF LAMIVUDINE IN CHRONIC HEPATITIS B PATIENTS WITH ACTIVE VIRAL REPLICATION AND DECOMPENSATED CIRRHOSIS UNDERGOING LIVER TRANSPLANTATION1Transplantation, 1996
- An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejectionHepatology, 1995
- RETRANSPLANTATION IN HEPATITIS B—A MULTICENTER EXPERIENCE1Transplantation, 1994
- "Occult" hepatitis B virus as source of infection in liver transplant recipientsThe Lancet, 1994
- Liver Transplantation in European Patients with the Hepatitis B Surface AntigenNew England Journal of Medicine, 1993
- High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitisGastroenterology, 1992
- Hepatitis B virus reinfection after orthotopic liver transplantation: Serological and clinical implicationsJournal of Hepatology, 1992
- PRELIMINARY EXPERIENCE WITH α-2b-INTERFERON THERAPY OF VIRAL HEPATITIS IN LIVER ALLOGRAFT RECIPIENTS1,2Transplantation, 1992